{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:40:01Z","timestamp":1748997601388,"version":"3.41.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.07.034","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T09:19:24Z","timestamp":1467796764000},"page":"302-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-term administration of tolvaptan increases myocardial remodeling and mortality via exacerbation of congestion in mice heart failure model after myocardial infarction"],"prefix":"10.1016","volume":"221","author":[{"given":"Akiyo","family":"Eguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Iwasaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Okuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Hirotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.07.034_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","article-title":"Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?","volume":"2","author":"Felker","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","article-title":"Furosemide and the progression of left ventricular dysfunction in experimental heart failure","volume":"44","author":"McCurley","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2011.03.005","article-title":"Furosemide induces mortality in a rat model of chronic heart failure","volume":"160","author":"Rokutan","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0020","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0025","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/CIRCHEARTFAILURE.112.968750","article-title":"Tolvaptan improves left ventricular dysfunction after myocardial infarction in rats","volume":"5","author":"Yamazaki","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCHEARTFAILURE.111.965392","article-title":"Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure","volume":"5","author":"Morooka","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.07.034_bb0040","doi-asserted-by":"crossref","first-page":"15883","DOI":"10.1073\/pnas.2136717100","article-title":"Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling","volume":"100","author":"Yamaguchi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0045","doi-asserted-by":"crossref","first-page":"e7590","DOI":"10.1371\/journal.pone.0075906","article-title":"Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats","volume":"8","author":"Naito","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.07.034_bb0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCHEARTFAILURE.109.916114","article-title":"Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure","volume":"3","author":"Costello-Boerrigter","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1254\/jphs.13086FP","article-title":"Tolvaptan attenuates left ventricular fibrosis after acute myocardial infarction in rats","volume":"123","author":"Yamazaki","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0060","first-page":"011","article-title":"Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study)","volume":"25","author":"Matsuzaki","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0065","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1152\/ajplegacy.1968.215.4.908","article-title":"Mechanism of renin release following furosemide diuresis in rabbit","volume":"215","author":"Meyer","year":"1968","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2125.1992.tb04103.x","article-title":"Captopril augments both basal and frusemide-induced natriuresis in normal man by suppression of circulating angiotensin II","volume":"34","author":"Motwani","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.26.1.137","article-title":"Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion","volume":"26","author":"He","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.07.034_bb0080","doi-asserted-by":"crossref","first-page":"36839","DOI":"10.1074\/jbc.M005552200","article-title":"Regulation of aquaporin-2 trafficking by vasopressin in the renal collecting duct. Roles of ryanodine-sensitive Ca2+ stores and calmodulin","volume":"275","author":"Chou","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ki.1976.76","article-title":"The osmoregulation of vasopressin","volume":"10","author":"Robertson","year":"1976","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1152\/ajprenal.00088.2008","article-title":"Vasopressin regulates the renin\u2013angiotensin\u2013aldosterone system via V1a receptors in macula densa cells","volume":"295","author":"Aoyagi","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1083\/jcb.120.2.371","article-title":"CHIP28 water channels are localized in constitutively water-permeable segments of the nephron","volume":"120","author":"Nielsen","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0100","doi-asserted-by":"crossref","first-page":"C1225","DOI":"10.1152\/ajpcell.1992.263.6.C1225","article-title":"Localization of the CHIP28 water channel in rat kidney","volume":"263","author":"Sabolic","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/ajprenal.90762.2008","article-title":"Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression","volume":"297","author":"Bouley","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0110","first-page":"199","article-title":"Angiotensin II actions in the rabbit proximal tubule. Angiotensin II mediated signaling mechanisms and electrolyte transport in the rabbit proximal tubule","volume":"14","author":"Romero","year":"1991","journal-title":"Ren. Physiol. Biochem."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0115","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.V8121813","article-title":"Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel alpha subunit in A6 renal cells","volume":"8","author":"May","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.2012050449","article-title":"Adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity","volume":"24","author":"Roos","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2016.07.034_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/clinchem\/21.2.190","article-title":"Comparison of methods for calculating serum osmolality form chemical concentrations, and the prognostic value of such calculations","volume":"21","author":"Dorwart","year":"1975","journal-title":"Clin. Chem."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316313833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316313833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:03:33Z","timestamp":1748995413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316313833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":26,"alternative-id":["S0167527316313833"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.034","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term administration of tolvaptan increases myocardial remodeling and mortality via exacerbation of congestion in mice heart failure model after myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}